Mary Hurwitz, PhD

Assistant Professor
Department of Pediatrics
Section of Hematology-Oncology,
Baylor College of Medicine

 


Contact Information:
mhurwitz@bcm.edu
832-824-4257


Education:
1980, PhD - University of Minnesota, Minneapolis, MN

Research Interests:
Dr. Mary Hurwitz is involved in preclinical and translational studies to support the use of gene therapy for ocular disorders. Using both in vitro and in vivo models of retinoblastoma, studies have been designed to examine viral-mediated gene therapy for the treatment of tumors in the eye. These studies include 1) elucidation of the unique properties of adenoviral transduction in the ocular environment, 2) investigation of the immune consequences of adenoviral-mediated gene transfer, 3) comparison of suicide gene therapy to gene replacement therapy, and 4) elucidation of the differences between metastatic and non-metastatic tumor development. In addition, options for gene replacement therapy for hereditary retinal degenerative diseases are being examined using a transgenic mouse model of Stargardt’s disease, a juvenile macular degenerative disorder caused by a mutation in a protein necessary for the recycling of the photon receptor retinal.

Selected Publications:
Plummer, T.H., Jr. and Hurwitz, M.Y.: Human plasma carboxypeptidase N: Isolation and characterization. J. Biol. Chem. 253:3907-3912, 1978.

Hurwitz, M.Y. and Edstrom, R.D.: A simple, sensitive radioimmunoassay for 5'-nucleotidase. Analyt. Biochem. 84:246-250, 1978.

Hurwitz, M.Y., Hurwitz, R.L., and Edstrom, R.D.: Inhibition of human lymphocyte cyclic nucleotide phosphodiesterases by the chlorinated adenosine analog DTA-35. J. Enzyme Inhibition 1:267-274, 1987.

Toda, T., Cameron, S., Sass, P., Zoller, M., Scott, J.D., McMullen, B., Hurwitz, M.Y., Krebs, E.G., and Wiggler, M.: Cloning and characterization of BCY1, a locus encoding a regulatory subunit of the cyclic AMP-dependent protein kinase in Saccharomyces cerevisiae. Mol. Cell. Biol. 7:1371-1377, 1987.


Hurwitz, M.Y., Putkey, J.A., Klee, C., and Means, A.R.: Domain II of calmodulin is involved in activation of calcineurin. FEBS Letters 238:82-86, 1988.

Rossen, R.D., Smith, C.W., Laughter, A.H., Noonan, C.A., Anderson, D.C., McShan, W.M., Hurwitz, M.Y., and Orson, F.M.: HIV-1 stimulated expression of CD11/CD18 integrins and ICAM-1: A possible mechanism for extravascular dissemination of HIV-1 infected cells. Trans. of the Assoc. Am. Phys. 102:117-130, 1989.

Olson, N.J., Pearson, R.B., Needleman, D., Hurwitz, M.Y., Kemp, B.E., and Means, A.R.: Regulatory and structural motifs of chicken gizzard myosin light chain kinase. Proc. Natl. Acad. Sci. USA 87:2284-2288, 1990.

Hurwitz, R.L., Hirsch, K.M., Clark, D.J., Holcombe, V.N., and Hurwitz, M.Y.: Induction of a calcium-calmodulin-dependent phosphodiesterase during PHA-stimulated lymphocyte mitogenesis. J. Biol. Chem. 265:8901-8907, 1990.

Sligh, J.E., Jr., Hurwitz, M.Y., Zhu, C., Anderson, D.C., and Beaudet, A.L.: An initiation codon mutation in CD18 in association with the moderate phenotype of leukocyte adhesion deficiency. J. Biol. Chem. 267:714-718, 1992.

Carcamo, B., Hurwitz, M.Y., Craft, C.M., and Hurwitz, R.L.: The pineal gland expresses the cone but not the rod cGMP phosphodiesterase. J. Neurochemistry 65:1085-1092, 1995.

Hurwitz, R.L., Srivastava, D., and Hurwitz, M.Y. Channel structure and divalent cation regulation of phototransduction. Behavioral and Brain Sciences 18:478, 1995.

Kommonen, B., Kylmä, T., Cohen, R.J., Penn, J.S., Paulin, L., Hurwitz, M.Y., and Hurwitz, R.L. Elevation of cGMP with normal expression and activity of rod cGMP-PDE in photoreceptor degenerate labrador retrievers. Ophthalmic Research 28:19-28, 1996.

Kylma T, Paulin L., Hurwitz M.Y., Hurwitz R.L., Kommonen, B.: Cloning of the cDNA encoding rod photoreceptor cGMP phosphodiesterase a and g subunits from the retinal degenerate labrador retriever dog. Res Vet Sci. 62:293-296, 1997.

Kylma T, Paulin L., Hurwitz M.Y., Hurwitz R.L., Kommonen, B.: Cloning and analysis of the cDNA encoding the rod G-protein transducin a, b1 and g1 subunits from the canine retina. Gene 193(1):1-4, 1997.

Hurwitz, M.Y., Marcus K.T., Chévez-Barrios P., Louie K., Aguilar-Cordova C.E., Hurwitz R.L. Suicide gene therapy for treatment of retinoblastoma in a murine model. Human Gene Therapy 10(3):441-448, 1999.

Chévez-Barrios P., Hurwitz M.Y., Louie K., Marcus K.T., Holcombe V.N., Schafer P., Aguilar-Cordova E., Hurwitz R.L. Metastatic and non-metastatic models of retinoblastoma. American Journal of Pathology 157(4):1405-1412, 2000.

Hurwitz R.L., Chévez-Barrios P., Chintagumpala M., Boniuk M., Hurwitz M.Y. Gene Therapy for Retinoblastoma. Proceedings of the 4th Great Basin Visual Science Symposium. 2000 vol 4 http://insight.med.utah.edu/gbs/gbs4/pdf/hurwitz_paper.pdf.

Suber M.L., Hurwitz M.Y., Chévez-Barrios P., Hurwitz R.L. Immune consequences of intraocular administration of modified adenoviral vectors. Human Gene Therapy 12: 833-838, 2001.

Hurwitz R.L., Shields C., Shields J., Chévez-Barrios P., Hurwitz, M.Y., Chintagumpala M. Retinoblastoma, In PA Pizzo and DG Poplack eds. Principles and Practice of Pediatric Oncology (4th edition). Lippincott-Raven, Philadelphia, 2002.

Hurwitz, R.L., Chevez-Barrios, P., Boniuk,M., Chintagumpala M., Hurwitz M.Y. Retinoblastoma: From Bench to Bedside In: Expert Reviews in Molecular Medicine, Cambridge Press, Cambridge, UK, 2003.

Chévez-Barrios P., Chintagumpala M., Mieler W., Boniuk M., Paysse E., Kozinetz C., Hurwitz M.Y., Hurwitz R.L. Response of Retinoblastoma with Vitreous Tumor Seeding to Adenovirus-mediated Delivery of Thymidine Kinase Followed by Ganciclovir. J Clin Onc. 23, 7927-7935, 2005.

Hurwitz, R.L., Shields, C., Shields, J., Chévez-Barrios, P., Hurwitz, M.Y. and Chintagumpala, M. Retinoblastoma In PA Pizzo and DG Poplack eds. Principles and Practice of Pediatric Oncology (5th edition). Lippincott-Raven, Philadelphia, 2006, pp 861-882.


 

CAGT Home | BCM Home | Privacy Notices

©2002, Cell And Gene Therapy, Baylor College of Medicine
One Baylor Plaza, N1002, Houston, TX 77030, (713)798-1246
URL: http://www.bcm.edu/genetherapy Email:cagt@bcm.edu
(Modified:August 15, 2006- SM)